604 related articles for article (PubMed ID: 23062316)
1. Usefulness of fetuin-A and C-reactive protein concentrations for prediction of outcome in acute coronary syndromes (from the French Registry of Acute ST-Elevation Non-ST-Elevation Myocardial Infarction [FAST-MI]).
Lim P; Moutereau S; Simon T; Gallet R; Probst V; Ferrieres J; Gueret P; Danchin N
Am J Cardiol; 2013 Jan; 111(1):31-7. PubMed ID: 23062316
[TBL] [Abstract][Full Text] [Related]
2. Anaemia to predict outcome in patients with acute coronary syndromes.
Ennezat PV; Maréchaux S; Pinçon C; Finzi J; Barrailler S; Bouabdallaoui N; Van Belle E; Montalescot G; Collet JP
Arch Cardiovasc Dis; 2013; 106(6-7):357-65. PubMed ID: 23806304
[TBL] [Abstract][Full Text] [Related]
3. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?
Correia LC; Lima JC; Rocha MS; D'Oliveira Junior A; Péricles Esteves J
Clin Chim Acta; 2007 Jan; 375(1-2):124-8. PubMed ID: 16916502
[TBL] [Abstract][Full Text] [Related]
4. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events.
Sinnaeve PR; Steg PG; Fox KA; Van de Werf F; Montalescot G; Granger CB; Knobel E; Anderson FA; Dabbous OH; Avezum A;
Arch Intern Med; 2009 Feb; 169(4):402-9. PubMed ID: 19237725
[TBL] [Abstract][Full Text] [Related]
5. ST-segment depression in non-ST elevation acute coronary syndromes: quantitative analysis may not provide incremental prognostic value beyond comprehensive risk stratification.
Yan AT; Yan RT; Tan M; Chow CM; Fitchett DH; Georgescu AA; Hassan Q; Luchansky J; Langer A; Goodman SG;
Am Heart J; 2006 Aug; 152(2):270-6. PubMed ID: 16875907
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of β-trace protein and cystatin C for the prediction of mortality in non ST segment elevation acute coronary syndromes.
Manzano-Fernández S; López-Cuenca A; Januzzi JL; Parra-Pallares S; Mateo-Martínez A; Sánchez-Martínez M; Pérez-Berbel P; Orenes-Piñero E; Romero-Aniorte AI; Avilés-Plaza F; Valdés-Chavarri M; Marín F
Am J Cardiol; 2012 Nov; 110(9):1240-8. PubMed ID: 22818840
[TBL] [Abstract][Full Text] [Related]
7. High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction.
Raposeiras Roubín S; Barreiro Pardal C; Roubín-Camiña F; Ocaranza Sanchez R; Alvarez Castro E; Paradela Dobarro B; García-Acuña JM; Aguiar Souto P; Jacquet Hervet M; Castromán MJ; Arufe I; Outes B; Reino-Maceiras MV; Abu Assi E; González-Juanatey JR
Rev Port Cardiol; 2013 Feb; 32(2):117-22. PubMed ID: 23337430
[TBL] [Abstract][Full Text] [Related]
8. Admission C-reactive protein serum levels and survival in patients with acute myocardial infarction with persistent ST elevation.
Canale ML; Stroppa S; Caravelli P; Petronio AS; Mariotti R; Mariani M; Balbarini A; Barsotti A
Coron Artery Dis; 2006 Dec; 17(8):693-8. PubMed ID: 17119378
[TBL] [Abstract][Full Text] [Related]
9. Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes.
Foussas SG; Zairis MN; Lyras AG; Patsourakos NG; Tsirimpis VG; Katsaros K; Beldekos DJ; Handanis SM; Mytas DZ; Karidis KS; Tselioti PG; Prekates AA; Ambrose JA
Am J Cardiol; 2005 Aug; 96(4):533-7. PubMed ID: 16098307
[TBL] [Abstract][Full Text] [Related]
10. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM
Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360
[TBL] [Abstract][Full Text] [Related]
11. Disparities in management patterns and outcomes of patients with non-ST-elevation acute coronary syndrome with and without a history of cerebrovascular disease.
Lee TC; Goodman SG; Yan RT; Grondin FR; Welsh RC; Rose B; Gyenes G; Zimmerman RH; Brossoit R; Saposnik G; Graham JJ; Yan AT;
Am J Cardiol; 2010 Apr; 105(8):1083-9. PubMed ID: 20381657
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of pregnancy-associated plasma protein A in patients with acute coronary syndrome.
Iversen KK; Dalsgaard M; Teisner AS; Schoos M; Teisner B; Nielsen H; Clemmensen P; Grande P
Am J Cardiol; 2009 Dec; 104(11):1465-71. PubMed ID: 19932776
[TBL] [Abstract][Full Text] [Related]
13. Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA] Augsburg Myocardial Infarction Registry).
Kuch B; von Scheidt W; Kling B; Heier M; Hoermann A; Meisinger C
Am J Cardiol; 2008 Nov; 102(9):1125-30. PubMed ID: 18940277
[TBL] [Abstract][Full Text] [Related]
14. Use of invasive strategy in non-ST-segment elevation myocardial infarction is a major determinant of improved long-term survival: FAST-MI (French Registry of Acute Coronary Syndrome).
Puymirat E; Taldir G; Aissaoui N; Lemesle G; Lorgis L; Cuisset T; Bourlard P; Maillier B; Ducrocq G; Ferrieres J; Simon T; Danchin N
JACC Cardiovasc Interv; 2012 Sep; 5(9):893-902. PubMed ID: 22995875
[TBL] [Abstract][Full Text] [Related]
15. Relation between previous angiotensin-converting enzyme inhibitor use and in-hospital outcomes in acute coronary syndromes.
Singh SM; Goodman SG; Yan RT; Dery JP; Wong GC; Gallo R; Grondin FR; Lai K; Lopez-Sendon J; Fox KA; Yan AT;
Am J Cardiol; 2012 Feb; 109(3):332-6. PubMed ID: 22078966
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of types of atrial fibrillation in acute coronary syndromes.
Lau DH; Huynh LT; Chew DP; Astley CM; Soman A; Sanders P
Am J Cardiol; 2009 Nov; 104(10):1317-23. PubMed ID: 19892044
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study.
Bogaty P; Boyer L; Simard S; Dauwe F; Dupuis R; Verret B; Huynh T; Bertrand F; Dagenais GR; Brophy JM
J Am Coll Cardiol; 2008 Jun; 51(24):2339-46. PubMed ID: 18549920
[TBL] [Abstract][Full Text] [Related]
18. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
[TBL] [Abstract][Full Text] [Related]
19. Comparison of acute coronary syndrome in patients receiving versus not receiving chronic dialysis (from the Global Registry of Acute Coronary Events [GRACE] Registry).
Gurm HS; Gore JM; Anderson FA; Wyman A; Fox KA; Steg PG; Eagle KA;
Am J Cardiol; 2012 Jan; 109(1):19-25. PubMed ID: 21974963
[TBL] [Abstract][Full Text] [Related]
20. Time-dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome.
Jahn J; Hellmann I; Maass M; Giannitsis E; Dalhoff K; Katus HA
Herz; 2004 Dec; 29(8):795-801. PubMed ID: 15599677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
